(Q43169344)

15 November 2017

title

Transcription-targeted gene therapy for androgen-independent prostate cancer (English)

1 reference

15 November 2017

0 references

8

1 reference

15 November 2017

9

Pamela J Russell

1 reference

15 November 2017

author name string

Rosetta Martiniello-Wilks

1

1 reference

15 November 2017

Tania Tsatralis

2

1 reference

15 November 2017

Peter Russell

3

1 reference

15 November 2017

Diana E Brookes

4

1 reference

15 November 2017

Dorethea Zandvliet

5

1 reference

15 November 2017

Linda J Lockett

6

1 reference

15 November 2017

Gerald W Both

7

1 reference

15 November 2017

publication date

1 May 2002

1 reference

15 November 2017

1 reference

15 November 2017

volume

9

1 reference

15 November 2017

issue

5

1 reference

15 November 2017

page(s)

443-452

1 reference

15 November 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Gene therapy for prostate cancer. New perspectives on an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Prodrug activation enzymes in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Relative activity and specificity of promoters from prostate-expressed genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Dressing up adenoviruses to modify their tropism.. Interview by Florence Paillard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Manipulation of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

Gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

inferred from DOI database lookup

7 January 2021

based on heuristic

Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700451

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700451

1 reference

Dimensions Publication ID

15 November 2017

1008092057

0 references

1 reference